FDA.reportPublic FDA data

Stanback

Manufacturer
Medtech Products Inc.
Effective date
2025-01-17
Label type
HUMAN OTC DRUG LABEL
Version
12
Source
full-release
Hydrated at
2026-06-01 00:52:43

Label at a glance#

ProductStanback
Active ingredientCAFFEINE, ASPIRIN
Label structure12 sections

Indications and uses

temporarily relieves minor aches and pains due to: headache muscular aches minor arthritis pain colds temporarily reduces fever

Dosage and administration

adults and children 12 years of age and over: place 1 powder on tongue every 6 hours, while symptoms persist. Drink a full glass of water with each dose, or may stir powder into a glass of water or other liquid. do not take more than 4 powders in 24 hours unless directed by a doctor. children under 12 years of age: ask a doctor.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

(in each powder)

Aspirin (NSAID*) 845 mg

*nonsteroidal anti-inflammatory drug

Purpose

OTC - PURPOSE SECTION

Pain reliever/fever reducer

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

(in each powder)

Caffeine 65 mg

Purpose

OTC - PURPOSE SECTION

Pain reliever aid

Uses

INDICATIONS & USAGE SECTION

  • temporarily relieves minor aches and pains due to:
    • headache
    • muscular aches
    • minor arthritis pain
    • colds

  • temporarily reduces fever

Warnings

WARNINGS SECTION

Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.

Allergy alert: Aspirin may cause a severe allergic reaction which may include:

  • hives
  • facial swelling
  • shock
  • asthma (wheezing)

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you

  • are age 60 or older
  • have had stomach ulcers or bleeding problems
  • take a blood thinning (anticoagulant) or steroid drug
  • take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
  • have 3 or more alcoholic drinks every day while using this product
  • take more or for a longer time than directed

Caffeine Warning: This product contains caffeine. Limit the use of caffeine-containing medications,foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and , occasionally, rapid heart beat.

Do not use

OTC - DO NOT USE SECTION

if you have ever had an allergic reaction to aspirin or any other pain reliever/fever reducer

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

  • stomach bleeding warning applies to you
  • you have a history of stomach problems, such as heartburn
  • you have high blood pressure, heart disease, liver cirrhosis, or kidney disease
  • you are taking a diuretic
  • you have asthma

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

taking a prescription drug for

  • diabetes
  • gout
  • arthritis

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • an allergic reaction occurs. Seek medical help right away.
  • you experience any of the following signs of stomach bleeding:
    • feel faint
    • vomit blood
    • have bloody or black stools
    • have stomach pain that does not get better

  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • redness or swelling is present
  • any new symptoms appear
  • ringing in the ears or a loss of hearing occurs

These could be signs of a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health care professional before use. It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years of age and over: place 1 powder on tongue every 6 hours, while symptoms persist. Drink a full glass of water with each dose, or may stir powder into a glass of water or other liquid.
  • do not take more than 4 powders in 24 hours unless directed by a doctor.
  • children under 12 years of age: ask a doctor.

Other information

OTHER SAFETY INFORMATION

  • each powder contains: potassium 50 mg
  • store below 25ºC (77ºF)

Inactive ingredients

INACTIVE INGREDIENT SECTION

docusate sodium, fumaric acid, lactose monohydrate, potassium chloride

Questions?

OTC - QUESTIONS SECTION

1-866-255-5197 

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

STANBACK

ASPIRIN (NSAID) - PAIN RELIEVER

CAFFEINE - PAIN RELIEVER AID


50 POWDERS

PRINCIPAL DISPLAY PANEL STANBACK ASPIRIN (NSAID) - PAIN RELIEVER CAFFEINE - PAIN RELIEVER AID 50 POWDERSPRINCIPAL DISPLAY PANEL STANBACK ASPIRIN (NSAID) - PAIN RELIEVER CAFFEINE - PAIN RELIEVER AID 50 POWDERS

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
994435aspirin 845 MG / caffeine 65 MG Oral PowderPSN12
1053327STANBACK Headache Powder 845 MG / 65 MG Oral Powder, Reformulated Jan 2011PSN12
1053327aspirin 845 MG / caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]SBD12
994435aspirin 845 MG / caffeine 65 MG Oral PowderSCD12
994435ASA 845 MG / Caffeine 65 MG Oral PowderSY12
1053327ASA 845 MG / Caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]SY12
1053327Stanback Headache Powder Reformulated Jan 2011 (ASA 845 MG / caffeine 65 MG) Oral PowderSY12

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ASPIRIN Pharmacologic Class Indexing3Indexing - Pharmacologic Class20191108
CAFFEINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9e37788c-b1bf-42ae-aac9-b60601606144Product name820260122
1527ac37-808d-43be-a63e-74e1258dbe46Product name920250219
7dea7767-9f52-b60a-5435-33cb9cc28baeProduct name420250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4Product name720250116
0ca83774-3f79-b837-5d6f-c210102f3bc8Product name620250114
bed0530e-f939-4541-956b-6928a2f6404fProduct name120241008
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name620240814
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
9fcb7a91-de07-4f00-aabf-e4d6fda403d5Product name820230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
41b814f3-0166-1c53-c9ef-a0794c7daf9dProduct name320221110
a590be26-846c-8659-a5a1-fb25907965dcProduct name220221110
d7724692-1155-4cc8-a415-22f5fc4aec35Product name620220216
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
bde672ba-4805-28d0-1986-73543d41b412Product name220210201
0ec3537a-6c9b-432a-896c-b9ea8723049aProduct name920200701
2dc76302-91c0-4c35-ad78-99adfb049c4bProduct name120200603
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
7916de40-e296-41f0-b811-6d0df1a33e2cProduct name920180627
e6065d4b-5ae1-476f-a40e-f2851cbb5d2bProduct name220180221
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name220171212
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
f212291f-05fe-9603-fc7e-bd73e38ce1e6Product name220161129
ade821ba-260a-47e2-bd89-743e27ac9906Product name120161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550Product name220151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657Product name120150929
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
2a21311a-89e2-0e83-2ebd-117f9798b2b2Product name120140508
332e86c3-7875-ca6e-f934-2206d2b31996Product name120140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94eProduct name120140508
96c2be53-8e44-452d-56a2-d255b2f1af2dProduct name120140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
d223c173-c39b-d764-47d4-d671d3088815Product name120140508
e01133ad-4dcd-c7f3-454b-2ff569ee160aProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63029-501-012020-04-23C16284748780-19d75b9cf-d2bc-f424-e053-dadaa90a57ceStanback
63029-501-022020-04-23C16284748780-19d75b9cf-d2bc-f424-e053-dadaa90a57ceStanback
63029-501-062020-04-23C16284748780-19d75b9cf-d2bc-f424-e053-dadaa90a57ceStanback
63029-501-242020-04-23C16284748780-19d75b9cf-d2bc-f424-e053-dadaa90a57ceStanback
63029-501-012020-01-31C16284748780-19d75b9cf-d2bc-f424-e053-dadaa90a57ceStanback
63029-501-022020-01-31C16284748780-19d75b9cf-d2bc-f424-e053-dadaa90a57ceStanback
63029-501-062020-01-31C16284748780-19d75b9cf-d2bc-f424-e053-dadaa90a57ceStanback
63029-501-242020-01-31C16284748780-19d75b9cf-d2bc-f424-e053-dadaa90a57ceStanback

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63029-501-01Stanback50 in 1 CARTONPOWDER5012
63029-501-02Stanback2 in 1 PACKAGEPOWDER212
63029-501-06Stanback6 in 1 PACKAGEPOWDER612
63029-501-24Stanback24 in 1 CARTONPOWDER2412

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63029-501STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.]12Current NDC, Legacy NDC, 4 package rows20250116_caaa1313-09e4-45aa-8836-346f6a370196.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63029-501-01EA - Each63029-5011a6a8f40-6b56-4858-b452-bcdc4963344a12022-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ASPIRINACTIVE INGREDIENTR16CO5Y76E1
CAFFEINEACTIVE INGREDIENT3G6A5W338E1
ASPIRINACTIVE MOIETYR16CO5Y76E1
CAFFEINEACTIVE MOIETY3G6A5W338E1
DOCUSATE SODIUMINACTIVE INGREDIENTF05Q2T2JA01
FUMARIC ACIDINACTIVE INGREDIENT88XHZ131311
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5X1
POTASSIUM CHLORIDEINACTIVE INGREDIENT660YQ98I101

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63029-50163029-501-01, 63029-501-24, 63029-501-02, 63029-501-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
NameUNIIKind
CAFFEINE3G6A5W338EACTIB
ASPIRINR16CO5Y76EACTIB
DOCUSATE SODIUMF05Q2T2JA0IACT
FUMARIC ACID88XHZ13131IACT
LACTOSE MONOHYDRATEEWQ57Q8I5XIACT
POTASSIUM CHLORIDE660YQ98I10IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 110 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
FUMARIC ACIDFUMARIC ACID88XHZ13131TABLET, CHEWABLE / ORAL120 mgExact identifier — unii+route
35 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET, FILM COATED / ORAL6 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131TABLET, EXTENDED RELEASE / ORAL84 mgExact identifier — unii+route
35 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10POWDER / RESPIRATORY (INHALATION)0.18 mgExact identifier — unii+dosage form
30 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10POWDER / RESPIRATORY (INHALATION)0.18 mgExact identifier — unii+dosage form
30 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET, FILM COATED / ORAL6 mgExact identifier — unii+route
40 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10CAPSULE, DELAYED RELEASE / ORAL2 mgExact identifier — unii+route
30 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET / ORAL50 mgExact identifier — unii+route
40 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET, COATED / ORAL1 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131SYRUP / ORAL0.75 mg/5mlExact identifier — unii+route
35 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0CAPSULE / ORAL8.2 mgExact identifier — unii+route
40 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET, FILM COATED / ORAL6 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131TABLET / ORAL115 mgExact identifier — unii+route
35 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131CAPSULE, EXTENDED RELEASE / ORAL240 mgExact identifier — unii+route
35 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL20 mgExact identifier — unii+route
40 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET, COATED / ORAL1 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131POWDER, FOR SOLUTION / ORAL2 mg/1mlExact identifier — unii+route
35 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0CAPSULE / ORAL8.2 mgExact identifier — unii+route
40 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10TABLET / ORAL231 mgExact identifier — unii+route
30 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET, FILM COATED / ORAL6 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131SUSPENSION / ORAL120 mgExact identifier — unii+route
35 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10SUSPENSION / ORALNAExact identifier — unii+route
30 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131SYRUP / ORAL0.75 mg/5mlExact identifier — unii+route
35 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0SUSPENSION, EXTENDED RELEASE / ORAL0.77 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131SUSPENSION / ORAL120 mgExact identifier — unii+route
35 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10CAPSULE, DELAYED RELEASE / ORAL2 mgExact identifier — unii+route
30 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0SUSPENSION, EXTENDED RELEASE / ORAL0.77 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131CAPSULE, EXTENDED RELEASE / ORAL240 mgExact identifier — unii+route
35 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10TABLET / ORAL231 mgExact identifier — unii+route
30 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131TABLET, EXTENDED RELEASE / ORAL84 mgExact identifier — unii+route
35 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0SUSPENSION / ORAL48 mgExact identifier — unii+route
40 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0CAPSULE, EXTENDED RELEASE / ORALNAExact identifier — unii+route
40 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XPOWDER / ORAL50 mgExact identifier — unii+route+dosage form
5 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL20 mgExact identifier — unii+route
40 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET, COATED / ORAL1 mgExact identifier — unii+route
40 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10POWDER / RESPIRATORY (INHALATION)0.18 mgExact identifier — unii+dosage form
30 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10POWDER / NASALNAExact identifier — unii+dosage form
30 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10SUSPENSION / ORALNAExact identifier — unii+route
30 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XPOWDER / ORAL50 mgExact identifier — unii+route+dosage form
5 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10CAPSULE, DELAYED RELEASE / ORAL2 mgExact identifier — unii+route
30 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131SYRUP / ORAL0.75 mg/5mlExact identifier — unii+route
35 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131SUSPENSION / ORAL120 mgExact identifier — unii+route
35 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0SUSPENSION / ORAL48 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131CAPSULE, EXTENDED RELEASE / ORAL240 mgExact identifier — unii+route
35 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10POWDER / NASALNAExact identifier — unii+dosage form
30 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131SUSPENSION / ORAL120 mgExact identifier — unii+route
35 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10SUSPENSION / ORALNAExact identifier — unii+route
30 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10POWDER / NASALNAExact identifier — unii+dosage form
30 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XPOWDER / ORAL50 mgExact identifier — unii+route+dosage form
5 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10TABLET / ORAL231 mgExact identifier — unii+route
30 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET, COATED / ORAL1 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131CAPSULE, EXTENDED RELEASE / ORAL240 mgExact identifier — unii+route
35 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0CAPSULE / ORAL8.2 mgExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131TABLET / ORAL115 mgExact identifier — unii+route
35 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131POWDER, FOR SOLUTION / ORAL2 mg/1mlExact identifier — unii+route
35 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10POWDER / NASALNAExact identifier — unii+dosage form
30 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0SUSPENSION, EXTENDED RELEASE / ORAL0.77 mgExact identifier — unii+route
40 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET, FILM COATED / ORAL6 mgExact identifier — unii+route
40 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0CAPSULE, EXTENDED RELEASE / ORALNAExact identifier — unii+route
40 equally ranked IID candidates
FUMARIC ACIDFUMARIC ACID88XHZ13131SYRUP / ORAL0.75 mg/5mlExact identifier — unii+route
35 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
StanbackASPIRIN AND CAFFEINEMedtech Products Inc.caaa1313-09e4-45aa-8836-346f6a3701962025-01-17WarningsExact identifier
ndc (package): 63029-501-24
ndc (package): 63029-501-06
ndc (package): 63029-501-02
ndc (package): 63029-501-01
ndc (product): 63029-501
ndc11 (package): 63029050124
ndc11 (package): 63029050101
ndc11 (package): 63029050106
ndc11 (package): 63029050102
spl id: c7af9f6c-018c-4612-b0a6-ba2e90fbec37
spl set id: caaa1313-09e4-45aa-8836-346f6a370196

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.